HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

lipocrine

anti-Alzheimer's drug; structure in first source

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Rosini, Michela: 2 articles (11/2011 - 10/2011)
2.	Andrisano, Vincenza: 1 article (11/2011)
3.	Bartolini, Manuela: 1 article (11/2011)
4.	Bolognesi, Maria Laura: 1 article (11/2011)
5.	Hrelia, Patrizia: 1 article (11/2011)
6.	Matera, Riccardo: 1 article (11/2011)
7.	Melchiorre, Carlo: 1 article (11/2011)
8.	Milelli, Andrea: 1 article (11/2011)
9.	Simoni, Elena: 1 article (11/2011)
10.	Tarozzi, Andrea: 1 article (11/2011)

Related Diseases

1.

Alzheimer Disease (Alzheimer's Disease)

10/01/2011 - "To evaluate the possibility for lipocrine to become a lead and to be developed as a multipotent drug for the treatment of Alzheimer's disease, ADMET (absorption, distribution, metabolism, excretion, and toxicity) parameters need to be determined. "
01/01/2009 - "MTDL design strategy in the context of Alzheimer's disease: from lipocrine to memoquin and beyond."
11/01/2011 - "Its structure was previously combined with that of the acetylcholinesterase inhibitor tacrine to give lipocrine (1), a lead compound multitargeted against Alzheimer's disease (AD). "

Related Drugs and Biologics

1.	Tacrine (Cognex)
2.	Cholinesterase Inhibitors (Anticholinesterases)
3.	memoquin